This trial will test a new protocol for managing drivelines, which are tubes that go from an external pump to an internal device. The new protocol includes a silver-based dressing and a new dressing change protocol. The goal is to reduce the risk of dermatitis and allergies.
1 Primary · 3 Secondary · Reporting Duration: 1 year
Active Control
Experimental Treatment
20 Total Participants · 2 Treatment Groups
Primary Treatment: Silverlon · No Placebo Group · N/A
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: